Transaction #28157 · Form 4 · 0000912282-26-001334

Helus Pharma Inc. · Purchase · Common Shares

Helus Pharma Inc. · Transacted September 29, 2026 · Filed October 1, 2026

Original SEC filing ↗

What does this filing report?

An SEC Form 4 filing for Helus Pharma Inc. records a purchase involving Common Shares on September 29, 2026. The reported quantity was 3,000. The filing date is October 1, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Transaction details

Company CIK
0001833141
Security type
Non-derivative
Acquisition type
Purchase · Code P
Quantity acquired
3,000
Reported price
12.91 · See footnotes
Reference value
38,730
Currency
Currency not specified
Ownership
Indirect
Holdings after transaction
3,000
Ownership description
Held by spouse
SEC acceptance time
Oct 1, 2026, 8:13 PM EDT
10b5-1 indication
Not indicated

Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.

Reporting owners

These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.

Company listings

HELP · Nasdaq · linked security

The linked listing is identified separately from other current company listings.

Filing footnotes & remarks

F1
Converted from Canadian purchase price of C$18.3157 using an exchange rate of C$1.4188 = US$1.00.

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.

This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.